145 related articles for article (PubMed ID: 23184080)
1. Assessing interactions between the associations of fibroblast growth factor receptor 2 common genetic variants and hormone receptor status with breast cancer risk.
Wang H; Yang Z; Zhang H
Breast Cancer Res Treat; 2013 Jan; 137(2):511-22. PubMed ID: 23184080
[TBL] [Abstract][Full Text] [Related]
2. Quantitative assessment of the effect of FGFR2 gene polymorphism on the risk of breast cancer.
Jia C; Cai Y; Ma Y; Fu D
Breast Cancer Res Treat; 2010 Nov; 124(2):521-8. PubMed ID: 20364400
[TBL] [Abstract][Full Text] [Related]
3. Association between fibroblast growth factor receptor-2 gene polymorphism and risk of breast cancer in Chinese populations: A HuGE review and meta-analysis.
Yang YB; Zhao ZX; Huang W; Liu H; Tan YL; Wang WM
J Cancer Res Ther; 2016; 12(2):543-9. PubMed ID: 27461607
[TBL] [Abstract][Full Text] [Related]
4. Association between FGFR2 (rs2981582, rs2420946 and rs2981578) polymorphism and breast cancer susceptibility: a meta-analysis.
Zhang Y; Zeng X; Liu P; Hong R; Lu H; Ji H; Lu L; Li Y
Oncotarget; 2017 Jan; 8(2):3454-3470. PubMed ID: 27966449
[TBL] [Abstract][Full Text] [Related]
5. Variants of FGFR2 and their associations with breast cancer risk: a HUGE systematic review and meta-analysis.
Cui F; Wu D; Wang W; He X; Wang M
Breast Cancer Res Treat; 2016 Jan; 155(2):313-35. PubMed ID: 26728143
[TBL] [Abstract][Full Text] [Related]
6. Genetic variants in FGFR2 and MAP3K1 are associated with the risk of familial and early-onset breast cancer in a South-American population.
Jara L; Gonzalez-Hormazabal P; Cerceño K; Di Capua GA; Reyes JM; Blanco R; Bravo T; Peralta O; Gomez F; Waugh E; Margarit S; Ibañez G; Romero C; Pakomio J; Roizen G
Breast Cancer Res Treat; 2013 Jan; 137(2):559-69. PubMed ID: 23225170
[TBL] [Abstract][Full Text] [Related]
7. A study on genetic variants of Fibroblast growth factor receptor 2 (FGFR2) and the risk of breast cancer from North India.
Siddiqui S; Chattopadhyay S; Akhtar MS; Najm MZ; Deo SV; Shukla NK; Husain SA
PLoS One; 2014; 9(10):e110426. PubMed ID: 25333473
[TBL] [Abstract][Full Text] [Related]
8. Hormone-dependent effects of FGFR2 and MAP3K1 in breast cancer susceptibility in a population-based sample of post-menopausal African-American and European-American women.
Rebbeck TR; DeMichele A; Tran TV; Panossian S; Bunin GR; Troxel AB; Strom BL
Carcinogenesis; 2009 Feb; 30(2):269-74. PubMed ID: 19028704
[TBL] [Abstract][Full Text] [Related]
9. Genetic variants in fibroblast growth factor receptor 2 (FGFR2) contribute to susceptibility of breast cancer in Chinese women.
Liang J; Chen P; Hu Z; Zhou X; Chen L; Li M; Wang Y; Tang J; Wang H; Shen H
Carcinogenesis; 2008 Dec; 29(12):2341-6. PubMed ID: 18845558
[TBL] [Abstract][Full Text] [Related]
10. Polymorphisms in second intron of the FGFR2 gene are associated with the risk of early-onset breast cancer in Chinese Han women.
Fu F; Wang C; Huang M; Song C; Lin S; Huang H
Tohoku J Exp Med; 2012 Mar; 226(3):221-9. PubMed ID: 22374580
[TBL] [Abstract][Full Text] [Related]
11. Genetic variants in FGFR2 and TNRC9 genes are associated with breast cancer risk in Pakistani women.
Mazhar A; Jamil F; Bashir Q; Ahmad MS; Masood M; Tanvir I; Rashid N; Waheed A; Afzal MN; Tariq MA
Mol Med Rep; 2016 Oct; 14(4):3443-51. PubMed ID: 27572905
[TBL] [Abstract][Full Text] [Related]
12. Replication of five GWAS-identified loci and breast cancer risk among Hispanic and non-Hispanic white women living in the Southwestern United States.
Slattery ML; Baumgartner KB; Giuliano AR; Byers T; Herrick JS; Wolff RK
Breast Cancer Res Treat; 2011 Sep; 129(2):531-9. PubMed ID: 21475998
[TBL] [Abstract][Full Text] [Related]
13. Association of polymorphisms in intron 2 of FGFR2 and breast cancer risk in Сhinese women.
Pan Z; Bao Y; Zheng X; Cao W; Cheng W; Xu X
Tsitol Genet; 2016; 50(5):59-64. PubMed ID: 30480917
[TBL] [Abstract][Full Text] [Related]
14. Correlation of FGFR2 rs2981582 polymorphisms with susceptibility to breast cancer: a case-control study in a Chinese population.
Shu J; Hui X; Zheng X; Zhao J; Xu Z; Chen Y; Lu C; Li J
J Int Med Res; 2019 Oct; 47(10):4753-4763. PubMed ID: 31448667
[TBL] [Abstract][Full Text] [Related]
15. Assessing interactions between common genetic variant on 2q35 and hormone receptor status with breast cancer risk: evidence based on 26 studies.
Huang T; Hong J; Lin W; Yang Q; Ni K; Wu Q; Sun J
PLoS One; 2013; 8(8):e69056. PubMed ID: 23976942
[TBL] [Abstract][Full Text] [Related]
16. Current evidence on the relationship between three polymorphisms in the FGFR2 gene and breast cancer risk: a meta-analysis.
Zhang J; Qiu LX; Wang ZH; Leaw SJ; Wang BY; Wang JL; Cao ZG; Gao JL; Hu XC
Breast Cancer Res Treat; 2010 Nov; 124(2):419-24. PubMed ID: 20300826
[TBL] [Abstract][Full Text] [Related]
17. Heterogeneity of Breast Cancer Associations with Common Genetic Variants in FGFR2 according to the Intrinsic Subtypes in Southern Han Chinese Women.
Liang H; Yang X; Chen L; Li H; Zhu A; Sun M; Wang H; Li M
Biomed Res Int; 2015; 2015():626948. PubMed ID: 26421298
[TBL] [Abstract][Full Text] [Related]
18. Assessing interactions between the association of common genetic variant at 1p11 (rs11249433) and hormone receptor status with breast cancer risk.
Chen Q; Shi R; Liu W; Jiang D
PLoS One; 2013; 8(8):e72487. PubMed ID: 23977306
[TBL] [Abstract][Full Text] [Related]
19. Association between 1p11-rs11249433 polymorphism and breast cancer susceptibility: evidence from 15 case-control studies.
Wu S; Cai J; Wang H; Zhang H; Yang W
PLoS One; 2013; 8(8):e72526. PubMed ID: 23977314
[TBL] [Abstract][Full Text] [Related]
20. Low-penetrance susceptibility variants and postmenopausal oestrogen receptor positive breast cancer.
Özgöz A; İçduygu FM; Yükseltürk A; ŞamlI H; Öztürk KH; Başkan Z
J Genet; 2020; 99():. PubMed ID: 32366738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
